PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 85 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,676,133 | -27.9% | 758,431 | -17.2% | 0.06% | -35.1% |
| Q1 2023 | $2,325,373 | +2368.5% | 915,501 | +1717.4% | 0.09% | +1780.0% |
| Q4 2022 | $94,201 | -92.0% | 50,375 | -89.0% | 0.01% | -91.1% |
| Q3 2022 | $1,180,000 | +2925.6% | 459,000 | +2155.2% | 0.06% | +2700.0% |
| Q2 2022 | $39,000 | -98.8% | 20,353 | -98.1% | 0.00% | -98.6% |
| Q1 2022 | $3,138,000 | +621.4% | 1,056,631 | +1167.9% | 0.14% | +429.6% |
| Q2 2020 | $435,000 | -26.4% | 83,334 | -55.6% | 0.03% | -62.0% |
| Q1 2020 | $591,000 | +46.7% | 187,755 | +87.8% | 0.07% | +144.8% |
| Q4 2019 | $403,000 | -41.2% | 100,000 | -37.0% | 0.03% | -43.1% |
| Q3 2019 | $685,000 | – | 158,650 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $33,805,000 | 33.22% |
| Abingworth LLP | 1,041,131 | $13,535,000 | 8.41% |
| Roumell Asset Management, LLC | 197,347 | $2,566,000 | 5.65% |
| Trellus Management Company, LLC | 89,700 | $1,166,000 | 2.12% |
| Prosight Management, LP | 148,682 | $1,933,000 | 1.21% |
| Broadfin Capital, LLC | 477,607 | $6,209,000 | 0.97% |
| HIGHLAND CAPITAL MANAGEMENT LP | 959,278 | $12,471,000 | 0.64% |
| ARMISTICE CAPITAL, LLC | 580,000 | $7,540,000 | 0.58% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,500 | $1,346,000 | 0.52% |
| Opus Point Partners Management, LLC | 20,000 | $260,000 | 0.51% |